| SciPort RLP

2024

First-in-Human Clinical Study with RNA-Immunotherapy Combination of IVAC-W-bre1-uID and IVAC_M_uID for Individualized Tumour Therapy in Triple Negative Breast Cancer Patients

Univ.-Prof. Dr. med. Marcus

2023 - 2030

Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B)

Prof. Dr. med. Georg

2021 - 2027

A Phase 1/2a First-in-human Study to Evaluate the Safety, Tolerability and Efficacy of IMA401, a bispecific T cell engaging receptor molecule (TCER®) in patients with recurrent and/or refractory solid tumors.

Marius,
Dr. med. Alexander

2021 - 2027

Pre-Screening for A Phase Ia/Ib first-in-human clinical trial to evaluate the safety, tolerability and Initial anti-tumor activity of IMA401, a bispecific T cell engaging receptor molecule (TCER®), in patients with recurrent and/or refractory solid tumors

Marius,
Dr. med. Alexander

2015 - 2017

Platelet function in pooled and apheresis platelet concentrates

Prof. Dr. Walter E.,
Katharina

2015 - 2017

Prevalence of Hepatitis E among Blood Donors

Dr. Stefan,
Prof. Dr. Walter E.

2013 - 2014

Production of autologous serum eye drops

Dr. Dana,
Dr. Ronland,
Dr. Stefan

2013 - 2014

Evaluation of the automated system DAYmate M for donor and patient blood grouping

Dr. Dana,
Prof. Dr. Walter E.,
Susanne

2013

Validation of Spectra Optia apheresis-system for collection of peripheral blood stem cells

Dr. Dana,
Prof. Dr. Walter E.

2012 - 2014

Stability of clotting factors in Fresh Frozen Plasma (FFP) produced and stored und different conditions

Dr. Stefan,
Prof. Dr. Walter

Transfusionszentrale

Klinikum / Johannes Gutenberg-Universität Mainz

Starten Sie Ihre Suche...

Transfusionszentrale

Klinikum / Johannes Gutenberg-Universität Mainz